Mikhail Blagosklonny is an oncologist and a distinguished researcher in the fields of cancer and aging. A native of Russia, he earned his Ph.D. in Experiemental Medicine and Cardiology at First Pavlov State Medical Universtiy in St. Petersburg, before settling in the United States to begin his career at New York Medical College in Valhalla, New York. He was more recently Professor of Oncology at the Roswell Park Cancer Institute in Buffalo, NY and has been an associate editor for PLOS ONE< the American Journal Of Pathology and International Journal Of Cancer. Dr. Blagosklonny is the current editor-in-chief of peer reviewed weekly medical journal Oncotarget, a publication focused on oncology research.
Dr. Blagosklonny has spent much of his career driven by a love of humanity and a belief that disease and aging can be conquered. Much of his research has focused on cell death and common factors in cancer and aging. Dr. Blagosklonny has long observed similarities in the death and decay of cells during the normal aging process and the spread of cancerous disease. He has learned from his studies that just as we can now fight and often conquer cancer, we can also use medical research and discovery to slow and even reverse the aging process, leading to increased longevity and less pain and discomfort in the aging process. Follow Mikhail on Google Scholar
Dr. Mikhail Blagosklonny has gotten much acclaim for his groundbreaking hypothesis concerning common factors in both aging and cancer that may be treatable by similar means. He has spent many years exploring these similarities and believes that just as the same processes may cause cell death and deterioration, the treatments that can reverse the cancer process may well help to halt and reverse the aging process. As a result of his research, Dr. Blagosklonny has proposed the use of popular cancer treatment Rapamycin to help slow or reverse cell death and slow the aging process.
Dr. Blagosklonny has spent many years in the field of oncology and believes that cancer is not only curable, but can, through proper research, become easier and less costly to treat. Current cancer treatments focus on destruction of cancerous cells and as such are often excruciating for the patient and prohibitively expensive. Dr. Blagosklonny believes that by shifting focus to preserving healthy cells and finding less destructive ways to eliminate cancerous growths, cancer patients will be healthier and less uncomfortable during the treatment process, leading to quicker recovery and less costly treatment. With quicker recovery times, fewer lost work houes and less physical deterioration after treatment, Dr. Blagosklonny envisions that cancer treatment will shift from a luxury to a disorder that is simpler and more cost effective to treat. Visit classroomvoices.org to read more about Mikhail.
While Dr. Blagosklonny continues to focus most of his research on cancer and the aging process, which are his areas of medical expertise, he dreams of a world which is entirely disease free. This is what led him into the field of medicine and this vision is what motivates him to continue to pursue new innovations.